Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$191.51 - $216.16 $4.98 Million - $5.62 Million
26,000 Added 46.43%
82,000 $17.4 Million
Q2 2023

Aug 14, 2023

BUY
$187.64 - $206.25 $10.5 Million - $11.6 Million
56,000 New
56,000 $10.8 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track One Fin Capital Management LP Portfolio

Follow One Fin Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One Fin Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on One Fin Capital Management LP with notifications on news.